| Incyte Corp | 69,79 / +0,01% |
| 日付/時刻 | 24.09. / 16:42 |
| 変化 / 変化(%) | 0,01 / +0,01% |
| Bid | 69,63 / 2 |
| Ask | 69,75 / 2 |
| 始値 | 69,47 |
| 直前終値 | 69,78 |
| 高値 | 70,09 |
| 安値 | 68,96 |
| 出来高 [USD] | 492.932,64 |
| 出来高 [Units] | 11.327 |
| Price fixings | 66 |
| ISIN | US45337C1027 |
| シンボル | INCY |
| 取引所 | Cboe US |
| 種類 | 株式 |
すべての取引所
| 取引所 | 直近 | 出来高 | |
|---|---|---|---|
| NASDAQ | 69,7700 |  |
301.169 |
| Cboe US | 69,79 | |
11.327 |
| IEX | 69,67 | |
8.059 |
| Moscow | 5.081,00 | |
751 |
| TradeGate | 59,480 | |
560 |
| London Domes.. | 69,86 | |
208 |
| gettex | 59,000 | |
104 |
| Frankfurt | 59,2000 |  |
100 |
| München | 59,70 | |
0 |
| Düsseldorf | 59,16 | |
0 |
| Berlin | 59,54 | |
0 |
| Lang & Schwa.. | 59,54 | |
|
| Stuttgart | 59,280 | |
|
| Quotrix | 59,4600 | |
|
| Mexico | 1.560,00 |  |
8 |
ニュース
- MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021
16.09.2021 / 08:45 - GlobeNewswire - Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
01.09.2021 / 13:05 - GlobeNewswire - Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
26.08.2021 / 22:05 - GlobeNewswire - BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer
19.08.2021 / 14:00 - GlobeNewswire - SEC Charges Biopharmaceutical Company Employee with Insider Trading
17.08.2021 / 16:26 - Newsfile Corp